BeStock  
Markets › Compare › TRAX vs BRVE

TRAX vs BRVE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TRAX · First Tracks Biotherapeutics$41.64 ▼ 6.34%
BRVE · Braveheart Bio$20.39 ▲ 5.81%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

557187103119Aug 6, '26Sep 29, '26Nov 20, '26
  • TRAX -8.1%
  • BRVE -31.6%

Head to head

MetricTRAXBRVE
Price$41.64$20.39
Change today▼ 6.34%▲ 5.81%
Market cap$1.75B$1.83B
Return, 3 months-3.8%-25.9%
Return, year to date––
Return, 1 year––
P/E (TTM)––
P/B11.63.7
P/E percentile vs own 5y5th4th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+25.1%+55.2%
Gross margin––
Operating margin––
Net margin––
Return on equity–-13.2%
Analyst target vs. price+81.1%+123.1%
Analyst buy share100%100%
RSI (14)4451
30-day volatility78.3%69.7%
Max drawdown, 1 year-39.7%-41.9%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BRVE is the largest of the group by market value.
  • BRVE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top